[Further contributions on the therapeutic action of Febutol in ORL].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010627:Phenethylamines; D011720:Pyrazoles; D011725:Pyridines; D010113:Oxyphenbutazone
Ulteriori contributi sulla azione terapeutica del Febutolo in O.R.L.